References
- Chengelis C P, Gad S C, Holson J. Regulatory toxicology. Raven, New York 1995
- Gad S C. Safety assessment for pharmaceuticals. Van Nostrand Reinhold, New York 1994
- Beyer K. Discovery, development and delivery of new drugs. Monographs in pharmacology and physiology, No. 12, Spectrum, New York 1978
- Sneader W. Drug development: From laboratory to clime. Wiley, New York 1986
- Spilker B. Multinational drug companies2d ed. Raven, New York 1994
- Fishlock D. Survival of the fittest drugs. Financial Times April, 1990; 24: 16–17
- FDA (Food and Drug Administration). New drug, antibiotic, and biologic drug product regulations. 21 CFR Parts 312. 314. 511, and 514. Federal Register 1987; 52(53)8798–8857
- Alder S, Zbinden G. National and international drug safety guidelines. MTC, ZollikonSwitzerland 1988
- Animal models in toxicology, S C Gad, C P Chengelis. Dekker, New York 1992
- Morton D. Expectations from animal studies. Animal toxicity studies: Their relevance for man, C E Lumley, S R Walker. CMR Workshop Series, Quay, Lancaster, PA 1990; 3–13
- Lumley C E. Clinical toxicity: could it have been predicted? Pre‐marketing experience. Animal toxicity studies: Their relevance for man, C E Lumley, S R Walker. CMR Workshop Series, Quay, Lancaster, PA 1990; 49–56
- Zbinden G, Eisner J, Boelsterli U A. Toxicological screening. Reg Toxicol Pharmacol 1984; 4: 275–286
- Gad S C. Principles of screening in toxicology: with special emphasis on applications to neurotoxicology. J Am Coll Toxicol 1989; 8: 21–27
- Gad S C. A tier testing strategy incorporating in vitro testing methods for pharmaceutical safety assessment. Humane Innovations and Alternatives in Animal Experimentation 1989; 3: 75–79
- Gad S C. In vitro toxicology. Raven, New York 1994
- Heywood R. Clinical toxicity—could it have been predicted? Post‐marketing experience. Animal toxicity studies: Their relevance for man, C E Lumley, S R Walker. CMR Workshop Series, Quay, Lancaster, PA 1990; 57–67
- Lumley C E, Walker S R. Animal toxicity studies: Their relevance for man. CMR Workshop Series, Quay, Lancaster, PA 1990; vii
- O'Grady J, Linet O I. Early phase drug evaluation in man. CRC, Boça Raton, FL 1990
- Scheuplein R J, Shoal S E, Brown R M. Role of pharmacokinetics in safety evaluation and regulatory considerations. Annu Rev Pharmacol Toxicol 1990; 30: 197–218
- Spector R, Park G D, Johnson G F, Vesell E S. Therapeutic drug monitoring. Clin Pharmacol Ther 1988; 43: 345–353